Introduction
Cancer is one of the most deadly diseases. According to the GLOBOCAN 2012 report, a total of 14.1 million new cancer cases were recorded, causing 8.2 million deaths.
1,2 1,3-Diaryl-2-propen-1-one, also known as chalcone, constitutes an important class of natural products. It exhibits a wide spectrum of pharmacological activities such as antimalarial, 3 antiinflammatory, 4 antioxidant, 5 anti-HIV, 6 and anticancer. 7 Additionally, the bielectrophilic character of the chalcone structure is used as an intermediate to prepare some heterocyclic rings such as pyrazolines, 8 isoxazoline, 9 pyrimidine, 10 thiazine, 11 oxazine, 12 and flavones 13 that are therapeutics. They react through a cyclocondensation reaction with binucleophiles. Therefore, synthesis is important to chemists for the discovery of new drugs, both organic and medicinal.
Cervical cancer is a malignant tumor arising from the cervix. It is the third most common cancer in women and the seventh overall, with an estimated 529,000 cases in 2008.
14 HeLa was the first human cell line established in culture 15 and since then it has become the most widely used human cell line in biological research.
HeLa cells have contributed to the characterization of important biological processes in many publications (more than 70,000), 16 while the C6 glioma model continues to be used for a variety of studies related to brain tumor biology. 17 These have included several studies related to tumor growth, invasion, migration, blood-brain barrier disruption, neovascularization, growth factor regulation and production, and biochemical studies.
18−20
Enzymes have a vital role in life because they catalyze all chemical reactions occurring in the living cells. Several diseases such as cancer have specific biochemical processes and different isoenzymes are overexpressed to contribute to the new metabolic state. 21, 22 Hence, these critical enzymes are important targets to cure many diseases, and selective inhibitors or activators are used as medicinal agents. Pyruvate kinase isoenzyme M2, overexpressed in cancer cells, performs a regulatory role in the production of ATP and the synthesis of intermediate metabolites for the synthesis of biomolecules. 23, 24 Many articles have reported that both its inhibitors and activators may be used to reduce the growth and proliferation of cancer cells. 25, 26 Carbonic anhydrase inhibitors find applications in the clinic such as antiglaucoma agents, diuretics, or antiepileptics. It was also suggested that carbonic anhydrase activators might be employed as drugs to treat disease occurring with a considerable decline of carbonic anhydrase in the brain, such as in Alzheimer disease, or during aging. 27 According to these data, we designed new chalcones bearing morpholine moiety to investigate their pharmacological activities. In this study, antiproliferative activities of (E)-3-(4-substitutedphenyl)-1-(4'-morpholinophenyl)prop-2-en-1-ones 1-7 were examined against HeLa and C6 cell lines at eight concentrations using the BrdU ELISA assay. The results of activity were compared with 5-fluorouracil (5-FU) as a standard drug.
Results and discussion

Chemistry
(E)-3-(4-Substituted phenyl)-1-(4'-morpholinophenyl)prop-2-en-1-one derivatives 2-7 were obtained by ClaisenSchmidt condensation of 4-substituted benzaldehyde with 4'-morpholinoacetophenone by the route shown in the Scheme. The structure and purity of the synthesized compounds were determined by elemental analysis and spectroscopic methods such as FT-IR, 1 H NMR, 13 C NMR, and 2D NMR analysis. Comparison of all spectral data and results of elemental analysis showed evidence of the formation of the target products.
Scheme. General synthetic pathway.
Generally, the FT-IR spectra of ( E)-3-(4-substituted phenyl)-1-(4'-morpholino phenyl)prop-2-en-1-one derivatives 1-7 showed a carbonyl (C=O) peak at 1644 to 1656 cm −1 and an (E) ethylenic (-CH=CH-) peak at 922 to 927 cm −1 . It also suggested morpholine -C-O-C-stretching at the 1185-1218 cm −1 and -C-N-C- Further examination of the HSQC, COSY, and HMBC spectra allowed the assignment of all remaining proton and carbon resonances for compound 7. The HSQC spectrum provided the determination of all protonated carbons, as shown in Figure 1 . The five extended spin systems (H 1 -H 2 , H 4 -H 5 , H 8 -H 9 , H 11 -H 12 , and H 15 -H 16 ) were determined in the 1 H, 1 H correlation spectra (COSY) of compound 7 ( Figure 2 ). As a result of the signals of H 5 , H 8 , and H 9 , the connection between the corresponding carbonyl group was determined by HMBC spectroscopy ( Figure   3 ). Other C-C connectivities that were inferred from the HMBC spectrum included connections from C 9 , C 10 , and C 3 to the morpholine ring ( Figure 3 ). Compound 7 was selected as a model compound to evaluate the NMR spectra, and the NMR data of other compounds are given in Section 3.
The mass spectra of all chalcones showed intensive molecular ions; the cleavage between the C β atom and 4-substituted phenyl ring gave the fragment C 
Antiproliferative activity results
Antiproliferative activities of compounds 1-7 and 5-FU were determined against C6 and HeLa cells. The IC 50 and IC 75 values of compounds 1-7 and 5-FU are given in Table 1 .
For the antiproliferative activities of compounds 1-7, a dose-dependent increase in activity against C6 cells was observed ( Figure 4A ). Compound 1 had almost the same antiproliferative activities as 5-FU, which is used as a standard compound against C6 cells at high concentrations ( Figure 4A ). However, compound 2 had moderate antiproliferative activity compared with 5-FU. The potency of inhibitions at 100 µ g/mL against C6 cells were as follows:
All the compounds were found to have greater effects against the C6 cell line than the HeLa cell line. The antiproliferative activities of compounds 1-7 were observed to increase against HeLa cells in a dosedependent manner ( Figure 4B ). All the compounds had weaker antiproliferative activities than 5-FU ( Figure   4B ). The potency of inhibitions at 100 µ g/mL against HeLa cells were as follows:
The structure-activity relationship is important to define the effects of groups. In this study, compound 1, having a nonsubstituted phenyl ring, exhibited better activity with an IC 50 value of 7.36 µ g/mL against C6 cells than HeLa cells. When the 4-substituted phenoxy group was attached to the phenyl ring, the antiproliferative activities of other compounds decreased. Only compound 3 having 4-(4-chlorophenoxy)phenyl moiety showed moderate activity against the C6 cell line (IC 50 : 10.60 µ g/mL).
Enzyme results
Effects of the synthetic derivatives on PKM2, hCA I, and hCA II are presented in Table 2 
Druglikeness properties
According to Lipinski's rules of five, 30 our results showed that the molecular weights of compounds 1-7 were not greater than 500. The number of groups that accepted hydrogen atoms was less than 10 and the number of those that donated hydrogen atoms was less than 5. All chalcones 2-7 had poor aqueous solubility with values of log P between 5.47 and 6.19. All data for the calculation of absorption (% ABS) according to Zhao et al. 31 are shown in Table 3 .
Conclusions
The synthesis and evaluation of the antiproliferative activity of chalcones carrying a morpholine ring were reported. The activity results showed that compound 1 was the most active against the C6 cell line among the tested compounds. Compound 1 may be found to be an anticancer drug candidate against C6 cells after further investigations. The effects of the compounds on the PKM2, hCA I, and hCA II were determined. As a result, compounds 2, 3, and 7 displayed inhibitory activities against hCA I. hCA II was inhibited by compounds 3 and 4 and activated by 1, 2, 6, and 7. The PKM2 enzyme was activated by compounds 2 and 3. When the results are taken into consideration, it can be suggested that compounds 2 and 3 may be ideal candidates for new molecule design in PKM2 activator investigations. Please see the Supplementary Material for more details.
Experimental
All chemicals and solvents were of analytical grade and were purchased from Sigma-Aldrich, Merck, or Roche. All chemical reactions were monitored with thin-layer chromatography using Merck silica gel 60 F 254 plates. Melting points were determined with an EZ-Melt melting point apparatus and were uncorrected. FT-IR spectra were recorded on a PerkinElmer Frontier spectrometer by an attenuated total reflectance apparatus (Waltham, 
General method for synthesis
4-Morpholinoacetophenone (0.01 mol) 4-substituted benzaldehyde (0.01 mol), and solid NaOH (0.03 mol) were added in methanol. The reaction mixture was stirred for 2 days at room temperature and was kept in a refrigerator overnight. The mixture was extracted with dichloromethane. The organic phase was dried with anhydrous MgSO 4 . The solvent was evaporated and the crude product was recrystallized from n-hexane /DCM. 
(E )-3-[4-(Phenoxy
(E )-3-[4-(4-Fluorophenoxy)phenyl-1-[4-(morpholin-4-yl)phenyl]prop-2-en-1-one (4)
Light 
(E )-3-[4-(4-Methoxyphenoxy
(E )-3-[4-(4-Methylphenoxy)phenyl-1-[4-(morpholin-4-yl)phenyl]prop-2-en-1-one (6)
(E )-3-[4-(4-Nitrophenoxy)phenyl-1-[4-(morpholin-4-yl)phenyl]prop-2-en-1-one (7)
Light yellow crystal, yield: 62%, mp: 180-182 
Biological activity
Cell culture and cell proliferation assay
HeLa and C6 cell lines in the cell culture conditions and antiproliferative activity in the experimental procedure were tested as described in the literature. 34, 35 Cell proliferation was measured by using BrdU Cell Proliferation ELISA according to the manufacturer's procedure. 34, 35 The percentage of inhibition of cell proliferation was calculated as follows:
IC 50 was calculated by ED50 plus v1.0 and the results were given as means ± SD of six values. P < 0.01 was considered statistically significant. The statistical analysis was performed using SPSS 13.5.
Enzyme assays
Carbonic anhydrase activities were determined according to the electrometric methods described by Wilbur and Anderson following the pH change from 8.3 to 6.3.
36 PKM2 activity was measured by spectrophotometry at 340 nm using a quartz cuvette with a 1-cm path length. 37 Stock solutions of derivatives were prepared in DMSO
(1 mg/mL) and diluted using distilled water for PKM2. 
